Axel Hinke Selected Research

Axel Hinke Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 09/2007
15	Neoplasms (Cancer) 09/2021 - 08/2005
14	Breast Neoplasms (Breast Cancer) 06/2020 - 12/2005
10	Multiple Myeloma 01/2020 - 06/2004
6	Adenocarcinoma 01/2022 - 08/2006
6	Rectal Neoplasms (Rectal Cancer) 03/2021 - 10/2002
6	Disease Progression 02/2016 - 09/2009
6	Infections 01/2016 - 10/2004
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 03/2004
4	Nausea 01/2018 - 01/2005
4	Vomiting 01/2018 - 01/2005
4	Lymphoma (Lymphomas) 01/2016 - 02/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2003
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2011
3	Pathologic Complete Response 10/2020 - 06/2009
3	Stomatitis 01/2018 - 02/2011
3	Neutropenia 02/2015 - 10/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 08/2006
3	Thrombocytopenia (Thrombopenia) 05/2013 - 11/2002
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016 - 04/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2013 - 11/2002
2	Alopecia (Baldness) 04/2013 - 06/2003
2	Hand-Foot Syndrome 08/2010 - 10/2002
2	Body Weight (Weight, Body) 08/2007 - 06/2003
1	Thrombocytosis (Thrombocythemia) 09/2021
1	Hyperthermia 03/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Pain (Aches) 01/2020
1	Exanthema (Rash) 12/2017
1	Cardiotoxicity 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Anastomotic Leak 11/2015
1	Neoplasm Metastasis (Metastasis) 02/2015

Drug/Important Bio-Agent (IBA)

12	Capecitabine (Xeloda)FDA Link 02/2016 - 10/2002
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 08/2007
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 09/2007
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2005
8	Bevacizumab (Avastin)FDA Link 06/2021 - 08/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 09/2007
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2005
5	AnthracyclinesIBA 01/2018 - 11/2002
4	Leucovorin (Folinic Acid)FDA Link 10/2015 - 09/2007
4	Epirubicin (Ellence)FDA LinkGeneric 07/2013 - 06/2009
4	Melphalan (Alkeran)FDA LinkGeneric 09/2010 - 10/2004
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 08/2006
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 04/2009
3	Thalidomide (Thalomid)FDA Link 01/2020 - 04/2009
3	fludarabineIBA 01/2016 - 11/2002
3	Rituximab (Mabthera)FDA Link 01/2016 - 11/2002
3	Bendamustine Hydrochloride FDA Link 01/2016 - 04/2013
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2015 - 06/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2015 - 10/2004
3	Gemcitabine FDA Link 10/2013 - 08/2006
3	Cetuximab (Erbitux)FDA Link 02/2011 - 03/2008
3	Prednisolone (Predate)FDA LinkGeneric 09/2010 - 11/2005
2	IpilimumabIBA 01/2022 - 06/2020
2	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2020
2	NivolumabIBA 01/2022 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2018
2	Circulating Tumor DNAIBA 01/2021 - 12/2020
2	Neurokinin-1 Receptor AntagonistsIBA 01/2018 - 05/2016
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 01/2017
2	Hormones (Hormone)IBA 01/2017 - 02/2015
2	human ERBB2 proteinIBA 01/2017 - 08/2007
2	Capsules (Microcapsules)IBA 08/2014 - 06/2009
2	Vincristine (Oncovin)FDA LinkGeneric 04/2013 - 11/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2011 - 08/2011
2	taxaneIBA 08/2010 - 08/2007
2	Amifostine (Ethyol)FDA LinkGeneric 09/2009 - 06/2003
2	Carboplatin (JM8)FDA LinkGeneric 09/2007 - 08/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	pazopanib FDA Link 01/2022
1	RamucirumabIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	tremelimumabIBA 10/2020
1	durvalumabIBA 10/2020
1	ametantrone (HAQ)IBA 01/2020
1	Guanosine Diphosphate (GDP)IBA 01/2020
1	ixazomibIBA 01/2020
1	Fibroblast Growth Factor 7 FDA Link 01/2018
1	Panitumumab (Vectibix)FDA Link 12/2017
1	Doxycycline (Periostat)FDA LinkGeneric 12/2017
1	Erythromycin (Erycette)FDA LinkGeneric 12/2017
1	purineIBA 01/2016

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
25	Therapeutics 01/2022 - 11/2005
7	Radiotherapy 02/2015 - 10/2002
6	Adjuvant Chemotherapy 01/2017 - 06/2010
5	Combination Drug Therapy (Combination Chemotherapy) 10/2015 - 08/2005
5	Prostatectomy (Retropubic Prostatectomy) 02/2015 - 03/2004
3	Chemoradiotherapy 10/2010 - 06/2003
3	Stem Cell Transplantation 09/2010 - 06/2004
2	Radioimmunotherapy 01/2022 - 10/2020
2	Neoadjuvant Therapy 03/2021 - 11/2015
2	Adjuvant Radiotherapy 08/2013 - 06/2009
1	Immunotherapy 06/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Induction Chemotherapy 11/2016
1	Autologous Transplantation 11/2016